Printer Friendly

WILSHIRE TECHNOLOGIES ACQUIRES PROPRIETARY HEMOSTAT PRODUCT FOR WOUND CARE LINE

 CARLSBAD, Calif., April 20 /PRNewswire/ -- Wilshire Technologies Inc. (AMEX: WIL) today announced it has executed a letter of intent for purchase of a proprietary hemostat product, which will be marketed by its Wilshire Medical Products subsidiary. Terms of the acquisition were not disclosed.
 The hemostat is a liquid product that has the ability to stop bleeding instantly in most cases. The market for hemostat products includes wound care, trauma, emergency care and the specialized market for hemophiliacs.
 Michael W. Crow, chairman and chief executive officer, stated, "We are very pleased with the acquisition of what we believe will become the premier hemostat product in the marketplace. The ability of the hemostat product to stop bleeding is of immense value in the wound care area and we anticipate it will be well received."
 Wilshire Medical Products intends to introduce the hemostat as a stand-alone product for consumer and emergency room situations, as well as incorporating it into the DermAssist(TM) family of wound care products.
 The company estimates that the U.S. medical market for hemostat products is more than $400 million annually while the consumer market for similar uses exceeds that amount considerably.
 Wilshire Medical Products is evaluating the timing of market introduction, but intends to initiate domestic and international sales in 1993.
 Wilshire Technologies develops, manufactures and markets disposable products for medical and clean room use. It has focused on proprietary products that incorporate its engineered materials, acquired polyurethane and other technologies, and its expertise in materials fabrication.
 -0- 4/20/93
 /CONTACT: Michael Crow, chairman & CEO, or Peter Kuebler, CFO, of Wilshire Technologies, 619-929-7200/
 (WIL)


CO: Wilshire Technologies Inc.; Wilshire Medical Products ST: California IN: MTC SU: TNM

JL -- SD001 -- 7829 04/20/93 09:14 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 20, 1993
Words:289
Previous Article:KIIS-VISION SPECTACULAR TO PREMIERE AT 'KIIS AND UNITE' AN ALL-STAR CONCERT REVUE TO BENEFIT THE PEDIATRIC AIDS FOUNDATION
Next Article:PRICE CLUB EXPANDS TO UNITED KINGDOM
Topics:


Related Articles
WILSHIRE TECHNOLOGIES SETS INTERNATIONAL SALES PACT FOR ITS ADVANCED DISPOSABLE MEDICAL PRODUCTS
WILSHIRE TECHNOLOGIES RECEIVES FDA 510(K) APPROVAL FOR INNOVATIVE DERMASSIST(TM) TRANSPARENT SITE DRESSING
NEW MATERIALS MAKE OLD PRODUCTS BETTER, SAFER, MORE EFFECTIVE
WILSHIRE MEDICAL PRODUCTS HIRES WOUND HEALING EXPERT AS MEDICAL/CLINICAL DIRECTOR
WILSHIRE TECHNOLOGIES INC. NAMES SIX CLINICIANS TO ITS WILSHIRE MEDICAL WOUND CARE ADVISORY BOARD
WILSHIRE TECHNOLOGIES INC. ANNOUNCES EXCLUSIVE LICENSE AGREEMENT WITH U.K.-BASED INNOVATIVE TECHNOLOGIES
WILSHIRE TECHNOLOGIES REPORTS RESULTS FOR THE SECOND QUARTER AND FIRST HALF OF FISCAL 1993
WILSHIRE TECHNOLOGIES ANNOUNCES SALE OF MEDICAL PRODUCTS DIVISION
Wilshire Technologies, Inc. Signs Letter of Intent with Foamex Asia Co., Ltd.
Kensey Nash Acquires Biomaterials Technology.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters